BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35567984)

  • 1. DeepAS - Chemical language model for the extension of active analogue series.
    Yoshimori A; Bajorath J
    Bioorg Med Chem; 2022 Jul; 66():116808. PubMed ID: 35567984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploration of structure-activity relationship determinants in analogue series.
    Peltason L; Weskamp N; Teckentrup A; Bajorath J
    J Med Chem; 2009 May; 52(10):3212-24. PubMed ID: 19397320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic mapping of R-group space enables the generation of an R-group replacement system for medicinal chemistry.
    Takeuchi K; Kunimoto R; Bajorath J
    Eur J Med Chem; 2021 Dec; 225():113771. PubMed ID: 34403977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational method for the systematic alignment of analogue series with structure-activity relationship transfer potential across different targets.
    Yoshimori A; Bajorath J
    Eur J Med Chem; 2022 Sep; 239():114558. PubMed ID: 35763865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational Method for Structure-Based Analysis of SAR Transfer.
    Bonanni D; Lolli ML; Bajorath J
    J Med Chem; 2020 Feb; 63(3):1388-1396. PubMed ID: 31939664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic Extraction of Analogue Series from Large Compound Collections Using a New Computational Compound-Core Relationship Method.
    Naveja JJ; Vogt M; Stumpfe D; Medina-Franco JL; Bajorath J
    ACS Omega; 2019 Jan; 4(1):1027-1032. PubMed ID: 31459378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical language models for molecular design.
    Bajorath J
    Mol Inform; 2024 Jan; 43(1):e202300288. PubMed ID: 38010610
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generative design of compounds with desired potency from target protein sequences using a multimodal biochemical language model.
    Chen H; Bajorath J
    J Cheminform; 2024 May; 16(1):55. PubMed ID: 38778425
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Designing highly potent compounds using a chemical language model.
    Chen H; Bajorath J
    Sci Rep; 2023 May; 13(1):7412. PubMed ID: 37150793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cephalostatin analogues--synthesis and biological activity.
    Flessner T; Jautelat R; Scholz U; Winterfeldt E
    Fortschr Chem Org Naturst; 2004; 87():1-80. PubMed ID: 15079895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Method for Systematic Analogue Search Using the Mega SAR Matrix Database.
    Yoshimori A; Horita Y; Tanoue T; Bajorath J
    J Chem Inf Model; 2019 Sep; 59(9):3727-3734. PubMed ID: 31468964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From SAR Diagnostics to Compound Design: Development Chronology of the Compound Optimization Monitor (COMO) Method.
    Yonchev D; Vogt M; Bajorath J
    Mol Inform; 2020 Dec; 39(12):e2000046. PubMed ID: 32282989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational analysis, alignment and extension of analogue series from medicinal chemistry.
    Yoshimori A; Bajorath J
    Future Sci OA; 2022 Aug; 8(7):FSO804. PubMed ID: 36248066
    [No Abstract]   [Full Text] [Related]  

  • 14. R-group replacement database for medicinal chemistry.
    Takeuchi K; Kunimoto R; Bajorath J
    Future Sci OA; 2021 Sep; 7(8):FSO742. PubMed ID: 34295541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SAR Matrix Method and an Artificially Intelligent Variant for the Identification and Structural Organization of Analog Series, SAR Analysis, and Compound Design.
    Yoshimori A; Bajorath J
    Mol Inform; 2020 Dec; 39(12):e2000045. PubMed ID: 32271994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of an activity landscape view taking compound-based feature probabilities into account.
    Zhang B; Vogt M; Bajorath J
    J Comput Aided Mol Des; 2014 Sep; 28(9):919-26. PubMed ID: 25001923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DeepCOMO: from structure-activity relationship diagnostics to generative molecular design using the compound optimization monitor methodology.
    Yonchev D; Bajorath J
    J Comput Aided Mol Des; 2020 Dec; 34(12):1207-1218. PubMed ID: 33015739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monitoring the Progression of Structure-Activity Relationship Information during Lead Optimization.
    Shanmugasundaram V; Zhang L; Kayastha S; de la Vega de León A; Dimova D; Bajorath J
    J Med Chem; 2016 May; 59(9):4235-44. PubMed ID: 26569348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic computational analysis of structure-activity relationships: concepts, challenges and recent advances.
    Peltason L; Bajorath J
    Future Med Chem; 2009 Jun; 1(3):451-66. PubMed ID: 21426126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global Assessment of Substituents on the Basis of Analogue Series.
    Takeuchi K; Kunimoto R; Bajorath J
    J Med Chem; 2020 Dec; 63(23):15013-15020. PubMed ID: 33253557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.